SFDA takes action against websites, social media accounts marketing unregistered peptides
RIYADH — The Saudi Food and Drug Authority (SFDA) announced that it had identified a number of unregistered peptide products being offered and marketed through websites and social media accounts without obtaining the required licenses from the authority. The action comes as part of its ongoing efforts to monitor products traded through online sales channels and verify their registration status…
The Saudi Food and Drug Authority (SFDA) has taken action against various websites and social media accounts that have been marketing unregistered peptide products. This crackdown follows the authority's commitment to ensuring online sales channels comply with registration requirements and safe distribution standards. The unregistered products have raised concerns due to their unknown origin and failure to meet essential criteria for safe transport, storage, and pharmaceutical supply chain standards.
Consequently, the SFDA highlighted that consumers may be misled by deceptive marketing claims about the products' quality and reliability, leading to potential health risks.
The authority has taken legal action against the owners of the non-compliant online stores, paving the way for their referral to the Public Prosecution. Penalties for such violations can include fines of up to SR5 million, imprisonment for up to five years, or both. The SFDA has emphasized that the circulation of unregistered products or those of unknown origin poses significant risks to consumer health and safety, as their safety, quality, and compliance with approved requirements cannot be verified.
It urged the public to verify product sources and registration status before making purchases and strongly discouraged obtaining pharmaceutical products from unreliable or unlicensed sources.
Written by urgent.news from Saudi Gazette's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
